Literature DB >> 15978026

Functional properties of neuronal nicotinic acetylcholine receptors in the chick retina during development.

Marzia Lecchi1, J Michael McIntosh, Sonia Bertrand, Avinoam B Safran, Daniel Bertrand.   

Abstract

Acetylcholine (ACh) has been recognized for a long time as a major neurotransmitter in the retina, however, little is known about the contribution of acetylcholine receptors in synaptic processing. Moreover, even less information is available concerning their role during development. To address this question further, we examined the physiological and pharmacological properties of neuronal nicotinic acetylcholine receptors (nAChRs) in retinal ganglion cells from embryonic (E) 12-18-day-old Leghorn chicks. Patch-clamp recordings in whole-cell configuration revealed that at E12 approximately 21% of the ganglion cells responded to acetylcholine pulses with inward currents. The number of responsive cells progressively increased to 57% at E15 to reach up to 15 positive cells out of 15 cells tested at E18. Acetylcholine-evoked responses could be subdivided, according to their time course, into fast and slowly desensitizing. Taking advantage of the selectivity of the frog toxin epibatidine (Epi), that preferentially activates heteromeric neuronal nicotinic acetylcholine receptors, we compared the currents evoked by this toxin vs. the effects of acetylcholine. A further characterization of the receptor diversity during development was to assess their sensitivity to the alpha-conotoxin MII (alpha-CTX-MII), which has been shown to preferentially block alpha6- and alpha3beta2-containing receptors. These data demonstrate that ganglion cells of the chick retina express multiple receptor subtypes that progressively develop as a function of retina maturation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978026     DOI: 10.1111/j.1460-9568.2005.04150.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  7 in total

1.  Lower urinary cotinine level is associated with a trend toward more myopic refractive errors in Korean adolescents.

Authors:  G E Nam; B E Hwang; Y-C Lee; J-S Paik; S-W Yang; Y-H Chun; K Han; Y G Park; S H Park
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

2.  The role of hydrogels with tethered acetylcholine functionality on the adhesion and viability of hippocampal neurons and glial cells.

Authors:  Zhaoli Zhou; Panpan Yu; Herbert M Geller; Christopher K Ober
Journal:  Biomaterials       Date:  2011-12-22       Impact factor: 12.479

Review 3.  Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype.

Authors:  Darlene H Brunzell
Journal:  Nicotine Tob Res       Date:  2012-04-06       Impact factor: 4.244

4.  Epibatidine application in vitro blocks retinal waves without silencing all retinal ganglion cell action potentials in developing retina of the mouse and ferret.

Authors:  Chao Sun; Colenso M Speer; Guo-Yong Wang; Barbara Chapman; Leo M Chalupa
Journal:  J Neurophysiol       Date:  2008-10-15       Impact factor: 2.714

5.  High affinity binding of epibatidine to serotonin type 3 receptors.

Authors:  Renaldo C Drisdel; Douglas Sharp; Tricia Henderson; Tim G Hales; William N Green
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

6.  Human Müller glia with stem cell characteristics differentiate into retinal ganglion cell (RGC) precursors in vitro and partially restore RGC function in vivo following transplantation.

Authors:  Shweta Singhal; Bhairavi Bhatia; Hari Jayaram; Silke Becker; Megan F Jones; Phillippa B Cottrill; Peng T Khaw; Thomas E Salt; G Astrid Limb
Journal:  Stem Cells Transl Med       Date:  2012-03-07       Impact factor: 6.940

7.  Acquisition of RGC phenotype in human Müller glia with stem cell characteristics is accompanied by upregulation of functional nicotinic acetylcholine receptors.

Authors:  Silke Becker; Shweta Singhal; Megan F Jones; Karen Eastlake; Phillippa B Cottrill; Hari Jayaram; G Astrid Limb
Journal:  Mol Vis       Date:  2013-09-13       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.